ANTIOXIDANT AND ANTI CLASTOGENIC POTENTIAL OF PIPER LONGUM L.
Objective: Present study was aimed to evaluate the antioxidant and anti clastogenic potential of methanol extract of Piper longum L (MEPL).
Methods: Chromatographic analysis was carried out using thermo GC-Trace Ultra Ver: 5.0 GC-MS. Antioxidant activities were assessed by DPPH free radical scavenging assay and reducing power assay. Based on the antioxidant activity, micronuclei formation in peripheral blood lymphocytes was analyzed. The protection afforded by Piper longum L. against the cytotoxicity of peripheral blood lymphocytes were confirmed by the micronucleus (MN) assay.
Results: The GC-MS analysis provides different peaks determining the presence of eighteen phytochemical compounds with different therapeutic activities. The methanol extract at a concentration of 40 Î¼g/ml showed the highest antioxidant activity by DPPH assay (68.42%) comparable to standard, ascorbic acid (73.68%). The reducing power observed was in the order of 40 Î¼g/ml>20 Î¼g/ml>10 Î¼g/ml. MEPL treatment decreased the frequency of MN in a concentration dependent manner.
Conclusion: A substantial amount of bioactive components are present in Piper longum L. A good correlation of the antioxidant capacity of the plant was established by different assay methodologies. MN test confirmed the anti clastogenic potential in peripheral blood lymphocytes.
Keywords: Piper longum L., MEPL, GC-MS, DPPH, reducing power, Micronuclei.
2. Satyavati G, Gupta AK, Tondon N. editors. Medicinal plants of India. Indian Council of Medicinal research. New Delhi; 1987.
3. Ramesh kumar KB, Anuaravind AP, Mathew PJ. Comparative phytochemical evaluation and antioxidant assay of Piper longum L. and Piper chaba Hunter used in Indian Traditional systems of medicine. J Herbs Spices Med Plants 2011;17:351-60.
4. Mehta A, Zitzmann N, Rudd PM. Alpha glucosidase inhibitors as potential broad based anti-viral agents. FEBS Lett 1998;430:17-20.
5. Arouma OI. Methodological considerations for characterizing potential antioxidant actions of bioactive components in plant foods. Mutat Res 2003;523-4, 9-20.
6. Abdelmigid HM. New trends in Genotoxocity testing of herbal medicinal plants. Intech Publishers; 2013.
7. Bootsma D, Kraemer KH, Cleaver JE, Hoeijmakers JH. Nucleotide excision repair syndromes: xeroderma pigmentosum, cockayne syndrome and trichothiodystrophy. In: The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York; 2001.
8. Westerink WM, Stevenson JC, Horbach GJ, Schoonen WG. The development of RAD51C, Cystatin A, and Nrf2 luciferaseâ€“reporter in metabolically competent HepG2 cells for the assessment of mechanism based genotoxicity assays and of oxidative stress in the early research phase of drug development. Mutat Res 2010;696:21-40.
9. Preston RJ, Sebastian JRS, Mc Fee AF. The in vitro human lymphocyte assay for assessing the clastogenicity of chemical agents. Mutat Res 1987;189:175-83.
10. Mensor LI, Menezes FS, Leitao GG, Reis AS, Dos santos T, Coube CS, et al. Screening of brazilian plants extracts for antioxidants activity by the use of DPPH free radical method. Phytother Res 2001;15:127-30.
11. Oyaizu M. Studies on product of browning reaction prepared from glucosamine. Jpn J Nutr 1986;44:307-15.
12. Bhuiyan NIMD, Begum J, Anwar MN. Volatile constituents of essential oils isolated from leaf and inflorescences of Piper longum Linn. Chittagong Univ J B Sci 2008;3:77-85.
13. Kedare SB, Singh RP. Genesis and development of DPPH method of antioxidant assay. J Food Sci Technol 2011;48:412â€“22.
14. Sujitha R, Bhimba BV, Sindhu MS, Arumugham P. Phytochemical evaluation and antioxidant activity of Nelumbo nucifera, Acorus calamus, and Piper longum. Int J Pharm Chem Sci 2013;2:1573-8.
15. Subhasini N, Thangathirupathi A, Lavanya N. Antioxidant activity of Trigonella foenumgraecum using various in vitro and ex vivo models. Int J Pharm Sci 2011;3:96-102.
16. Morse MA, Stoner GD. Cancer chemoprevention: Principles and Prospects. Carcinogenesis 1993;14:1737-46.
17. Bonassi S, El-Zein R, Bolognesi C, Fenech M. Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies. Mutagenesis 2011;26:93-100